NPCE NeuroPace Inc

$15.60 +2.90%

Healthcare · Surgical & Medical Instruments & Apparatus

NeuroPace Inc (NPCE) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $532 million. Shares last traded at $15.60, 21.2% below their 52-week high. Over the past year the stock is up 44.4%. Net profit margin is -21.5%, below the peer median of -7.6%. Revenue grew 25.1% year over year.

Market Cap

$532M

Shares Out

34.1M

EPS (TTM)

$-1.46

P/E Ratio

—

P/S Ratio

5.32

P/B Ratio

36.80

Dividend / Share

—

Dividend Yield

—

52-Week High

$19.80

52-Week Low

$7.69

Volume

4,995

Avg Vol (3m)

9,642.286

Performance

-1.27%

-1.55%

+18.77%

-1.76%

YTD

+2.83%

+44.44%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

46.20

SMA (50)

$16.24

SMA (200)

$14.29

Price vs SMA50

-3.97%

Price vs SMA200

+9.13%

ATR (14)

$0.80

Financials

Revenue

$100M

Net Income

$-21M

Gross Margin

77.2%

Operating Margin

-16.3%

Net Margin

-21.5%

Return on Equity

-148.5%

Return on Assets

-21.7%

Current Ratio

5.38

Debt / Equity

4.08

Revenue Growth (YoY)

+25.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.20	2026-05-12
FY 2025	$-0.66	2026-03-03
Q3 2025	$-0.58	2025-11-04
Q2 2025	$-0.47	2025-08-12
Q1 2026	$-0.21	2026-05-12
FY 2025	$-0.93	2026-03-03

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NPCE vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

5.32 / 2.52 med

+111% premium

Net margin vs peers

-21.5% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.